Global Drugs for HIV Market Research Report 2021

1 Drugs for HIV Market Overview

• 1.1 Product Overview and Scope of Drugs for HIV
• 1.2 Drugs for HIV Segment by Type
  • 1.2.1 Global Drugs for HIV Sales Growth Rate Comparison by Type (2021-2027)
  • 1.2.2 Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
  • 1.2.3 Integrase Inhibitors
  • 1.2.4 Combination HIV Medicines
  • 1.2.5 Others
• 1.3 Drugs for HIV Segment by Application
  • 1.3.1 Drugs for HIV Sales Comparison by Application: (2021-2027)
  • 1.3.2 Hospital Pharmacies
  • 1.3.3 Retail Pharmacies
  • 1.3.4 Online Pharmacies
  • 1.3.5 Others
• 1.4 Global Drugs for HIV Market Size Estimates and Forecasts
  • 1.4.1 Global Drugs for HIV Revenue 2016-2027
  • 1.4.2 Global Drugs for HIV Sales 2016-2027
  • 1.4.3 Drugs for HIV Market Size by Region: 2016 Versus 2021 Versus 2027

2 Drugs for HIV Market Competition by Manufacturers

• 2.1 Global Drugs for HIV Sales Market Share by Manufacturers (2016-2021)
• 2.2 Global Drugs for HIV Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Global Drugs for HIV Average Price by Manufacturers (2016-2021)
• 2.4 Manufacturers Drugs for HIV Manufacturing Sites, Area Served, Product Type
• 2.5 Drugs for HIV Market Competitive Situation and Trends
  • 2.5.1 Drugs for HIV Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Drugs for HIV Players Market Share by Revenue
  • 2.5.3 Global Drugs for HIV Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Drugs for HIV Retrospective Market Scenario by Region

• 3.1 Global Drugs for HIV Retrospective Market Scenario in Revenue by Region: 2016-2021
• 3.2 Global Drugs for HIV Retrospective Market Scenario in Sales by Region: 2016-2021
• 3.3 North America Drugs for HIV Market Facts & Figures by Country
  • 3.3.1 North America Drugs for HIV Sales by Country
  • 3.3.2 North America Drugs for HIV Revenue by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Drugs for HIV Market Facts & Figures by Country
  • 3.4.1 Europe Drugs for HIV Sales by Country
  • 3.4.2 Europe Drugs for HIV Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Drugs for HIV Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Drugs for HIV Sales by Region
  • 3.5.2 Asia Pacific Drugs for HIV Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Drugs for HIV Market Facts & Figures by Country
  • 3.6.1 Latin America Drugs for HIV Sales by Country
  • 3.6.2 Latin America Drugs for HIV Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
• 3.7 Middle East and Africa Drugs for HIV Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Drugs for HIV Sales by Country
  • 3.7.2 Middle East and Africa Drugs for HIV Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 UAE

4 Global Drugs for HIV Historic Market Analysis by Type

• 4.1 Global Drugs for HIV Sales Market Share by Type (2016-2021)
• 4.2 Global Drugs for HIV Revenue Market Share by Type (2016-2021)
• 4.3 Global Drugs for HIV Price by Type (2016-2021)

5 Global Drugs for HIV Historic Market Analysis by Application

• 5.1 Global Drugs for HIV Sales Market Share by Application (2016-2021)
• 5.2 Global Drugs for HIV Revenue Market Share by Application (2016-2021)
• 5.3 Global Drugs for HIV Price by Application (2016-2021)

6 Key Companies Profiled

• 6.1 ViiV Healthcare
  • 6.1.1 ViiV Healthcare Corporation Information
  • 6.1.2 ViiV Healthcare Description and Business Overview
  • 6.1.3 ViiV Healthcare Drugs for HIV Sales, Revenue and Gross Margin (2016-2021)
  • 6.1.4 ViiV Healthcare Product Portfolio
  • 6.1.5 ViiV Healthcare Recent Developments/Updates
• 6.2 Gilead Sciences, Inc
  • 6.2.1 Gilead Sciences, Inc Corporation Information
  • 6.2.2 Gilead Sciences, Inc Description and Business Overview
  • 6.2.3 Gilead Sciences, Inc Drugs for HIV Sales, Revenue and Gross Margin (2016-2021)
  • 6.2.4 Gilead Sciences, Inc Product Portfolio
  • 6.2.5 Gilead Sciences, Inc Recent Developments/Updates
• 6.3 Merck Sharp & Dohme Corp
  • 6.3.1 Merck Sharp & Dohme Corp Corporation Information
  • 6.3.2 Merck Sharp & Dohme Corp Description and Business Overview
  • 6.3.3 Merck Sharp & Dohme Corp Drugs for HIV Sales, Revenue and Gross Margin (2016-2021)
  • 6.3.4 Merck Sharp & Dohme Corp Product Portfolio
  • 6.3.5 Merck Sharp & Dohme Corp Recent Developments/Updates
• 6.4 Bristol-Myers Squibb Company
  • 6.4.1 Bristol-Myers Squibb Company Corporation Information
  • 6.4.2 Bristol-Myers Squibb Company Description and Business Overview
  • 6.4.3 Bristol-Myers Squibb Company Drugs for HIV Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Bristol-Myers Squibb Company Product Portfolio
  • 6.4.5 Bristol-Myers Squibb Company Recent Developments/Updates
• 6.5 Janssen Pharmaceuticals, Inc.
  • 6.5.1 Janssen Pharmaceuticals, Inc. Corporation Information
  • 6.5.2 Janssen Pharmaceuticals, Inc. Description and Business Overview
  • 6.5.3 Janssen Pharmaceuticals, Inc. Drugs for HIV Sales, Revenue and Gross Margin (2016-2021)
  • 6.5.4 Janssen Pharmaceuticals, Inc. Product Portfolio
  • 6.5.5 Janssen Pharmaceuticals, Inc. Recent Developments/Updates
• 6.6 Theratechnologies Inc.
  • 6.6.1 Theratechnologies Inc. Corporation Information
  • 6.6.2 Theratechnologies Inc. Description and Business Overview
  • 6.6.3 Theratechnologies Inc. Drugs for HIV Sales, Revenue and Gross Margin (2016-2021)
  • 6.6.4 Theratechnologies Inc. Product Portfolio
  • 6.6.5 Theratechnologies Inc. Recent Developments/Updates
• 6.7 Mylan Pharmaceuticals Inc.
  • 6.6.1 Mylan Pharmaceuticals Inc. Corporation Information
  • 6.6.2 Mylan Pharmaceuticals Inc. Description and Business Overview
  • 6.6.3 Mylan Pharmaceuticals Inc. Drugs for HIV Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Mylan Pharmaceuticals Inc. Product Portfolio
  • 6.7.5 Mylan Pharmaceuticals Inc. Recent Developments/Updates
• 6.8 Genentech, Inc.
  • 6.8.1 Genentech, Inc. Corporation Information
  • 6.8.2 Genentech, Inc. Description and Business Overview
  • 6.8.3 Genentech, Inc. Drugs for HIV Sales, Revenue and Gross Margin (2016-2021)
  • 6.8.4 Genentech, Inc. Product Portfolio
  • 6.8.5 Genentech, Inc. Recent Developments/Updates
• 6.9 AbbVie Inc.
  • 6.9.1 AbbVie Inc. Corporation Information
  • 6.9.2 AbbVie Inc. Description and Business Overview
  • 6.9.3 AbbVie Inc. Drugs for HIV Sales, Revenue and Gross Margin (2016-2021)
  • 6.9.4 AbbVie Inc. Product Portfolio
  • 6.9.5 AbbVie Inc. Recent Developments/Updates

7 Drugs for HIV Manufacturing Cost Analysis

• 7.1 Drugs for HIV Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Drugs for HIV
• 7.4 Drugs for HIV Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Drugs for HIV Distributors List
• 8.3 Drugs for HIV Customers

9 Drugs for HIV Market Dynamics

• 9.1 Drugs for HIV Industry Trends
• 9.2 Drugs for HIV Growth Drivers
• 9.3 Drugs for HIV Market Challenges
• 9.4 Drugs for HIV Market Restraints

10 Global Market Forecast

• 10.1 Drugs for HIV Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Drugs for HIV by Type (2022-2027)
  • 10.1.2 Global Forecasted Revenue of Drugs for HIV by Type (2022-2027)
• 10.2 Drugs for HIV Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Drugs for HIV by Application (2022-2027)
  • 10.2.2 Global Forecasted Revenue of Drugs for HIV by Application (2022-2027)
• 10.3 Drugs for HIV Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Drugs for HIV by Region (2022-2027)
  • 10.3.2 Global Forecasted Revenue of Drugs for HIV by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List